Ok Sarah Shin, Ph.D.
Blood Res 2017; 52(3): 151-152Young-Ho Lee, M.D. Ph.D.
Blood Res 2017; 52(3): 153-156Praveen Sharma, and Jasmina Ahluwalia
Blood Res 2017; 52(3): 157-157Huijeong Jeong, and Jooryung Huh
Blood Res 2017; 52(3): 158-158Liren Qian, Ciprian Tomuleasa, Ioan-Alexandru Florian, Jianliang Shen, Ioan-Stefan Florian, Mihnea Zdrenghea, and Delia Dima
Blood Res 2017; 52(3): 159-166Kyu Ho Lee, Young Tae Lim, Jeong Ok Hah, Yu Kyung Kim, Chae Hoon Lee, and Jae Min Lee
Blood Res 2017; 52(3): 167-173Jae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, Gi June Min, Sung-Soo Park, Young-Woo Jeon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, and Woo-Sung Min
Blood Res 2017; 52(3): 174-183Jung Yeon Lee, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, Yundeok Kim, Soo-Jeong Kim, Jin Seok Kim, Shin Young Hyun, Yoo Hong Min, and June-Won Cheong
Blood Res 2017; 52(3): 184-192Hyun-Young Kim, Mi-Ae Jang, Hee-Jin Kim, Seok Jin Kim, Won Seog Kim, and Sun-Hee Kim
Blood Res 2017; 52(3): 193-199Jeongkuk Seo, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Jae Hoon Lee, Jun Shik Hong, Gyeong-Won Lee, Sung Yong Oh, Ji-Hyun Lee, Dok Hyun Yoon, Won-Sik Lee, Hyo Jung Kim, Jae-Yong Kwak, Hye Jin Kang, Jae-Cheol Jo, Yong Park, Ho Sup Lee, Hyo-Jin Kim, and Cheolwon Suh
Blood Res 2017; 52(3): 200-206
Kaplan-Meier graph depicting progression-free survival (PFS) of patients with advanced stage marginal zone lymphoma (MZL) treated with R-CVP chemotherapy (PFS at 3 years was 69.6%).
|@|~(^,^)~|@|Kaplan-Meier survival plots;